Executive Director and Chief Executive Officer
Chi-Med
Hong Kong
Mr Hogg has been an Executive Director and the Chief Executive Officer since 2006. He is also a member of the Technical Committee of the Company. He joined Hutchinson China in 2000 and has since led all aspects of the creation, implementation and management of the Company’s strategy, business and listing. This includes the creation of the Company’s start-up businesses and the acquisition and operational integration of assets that led to the formation of the Company’s China joint ventures.
discovery, development and commercialization of targeted therapies for oncology and immunological diseases.